Evidence map›Paper›PMID 41974724›Full record

ArticleNature communications2026

Host-microbiome archetypes differentiate infection from pathogen carriage in the human lower airway.

Emily C Lydon, Padmini Deosthale, Abigail Glascock, Hoang Van Phan, Christina M Osborne, Matthew K Leroue, Jawara Allen, Eran Mick, Brandie D Wagner, Joseph L DeRisi and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emily C Lydon *Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3510-6254
Padmini Deosthale *Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Abigail Glascock *Chan Zuckerberg Biohub, San Francisco, CA, USA.
Hoang Van PhanDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Christina M OsborneDivision of Pediatric Infectious Diseases, University of Pennsylvania, Perelman School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Matthew K LeroueDepartment of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA.
Jawara AllenDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Eran MickDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Brandie D WagnerDepartment of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA.
Joseph L DeRisiChan Zuckerberg Biohub, San Francisco, CA, USA.
Lilliam AmbroggioDepartment of Pediatrics, University of Colorado and Children's Hospital Colorado, Aurora, CO, USA.
Peter M MouraniDepartment of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Charles R LangelierDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA. chaz.langelier@ucsf.edu.ORCID http://orcid.org/0000-0002-6708-4646

Funding

CTSA K12 Program at University of Colorado DenverK12TR004412 · NCATS · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM · 2024 to 2026
$3.2M
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated PneumonR01HL124103 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MOURANI, PETER M, SONTAG, MARCI K · 2014 to 2017
$2.7M
Integrated Host/Microbe Metagenomics to Improve Lower Respiratory Tract Infection Diagnosis in Critically Ill ChildrenR01HL155418 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANGELIER, CHARLES · 2021 to 2024
$1.6M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) R01AI182308NCATS NIH HHS K12 TR004412U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL124103U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL155418
6 · The paper itself

Abstract

Distinguishing lower respiratory tract infection (LRTI) from incidental pathogen carriage (IPC) is clinically challenging. The immunologic and microbial factors defining the states of LRTI and IPC are poorly understood. Here, we perform host-microbe metatranscriptomic profiling of tracheal aspirates from 326 mechanically ventilated children with clinically adjudicated LRTI (n = 207), IPC (n = 70), or non-infectious respiratory failure (n = 49). In the airway microbiome, LRTI shows reduced alpha diversity and taxonomic richness, while IPC displays greater bacterial abundance, enrichment in respiratory anaerobes, and increased metabolic activity. At the host level, patients with LRTI exhibit a distinct lower airway transcriptional signature of innate and adaptive immune activation compared to those with IPC, who have similar transcriptional profiles to uninfected controls. Mediation analyses suggest the airway microbiome influences the host response to pathogens. An integrated host-microbe metatranscriptomic classifier accurately discriminates LRTI from IPC and controls (AUC = 0.89, 95% confidence interval (CI) 0.85-0.92). The single gene FABP4, encoding a macrophage-associated lipid chaperone and recently described pneumonia biomarker, performs similarly when combined with alpha diversity; FABP4 protein alone achieves an AUC = 0.88 (95% CI 0.82-0.93). Together, our findings reveal distinct ecological and immunologic archetypes defining LRTI and IPC, and support data-driven, biology-informed LRTI diagnostics incorporating host and microbial features.

Indexed as

Carrier StateHost Microbial InteractionsMicrobiotaRespiratory Tract InfectionsTracheaBacteriaChildChild, PreschoolFemaleGene Expression ProfilingHumansInfantMaleTranscriptome

Identifiers

PMID41974724
PMCPMC13250161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.